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Summary To compare the relative heat sensitivities of human normal and neoplastic cells of the same tissue
type, a study was carried out of the relative sensitivities to heat of granulocyte/macrophage progenitor cells
(CFU-GM) derived from the peripheral blood and bone marrow of normal subjects and patients with chronic
granulocytic leukaemia (CGL). Nucleated haemopoietic cells were incubated at temperatures in the range
41.5°C to 44.0°C for various periods before culture in agar. The results of these experiments showed that
CFU-GM from normal blood were consistently less sensitive to damage by heat than normal marrow CFU-
GM. There was no comparable difference in the relative heat sensitivities of CFU-GM from blood and
marrow of patients with CGL and no significant difference between the heat sensitivities of CFU-GM derived
from marrow from normal individuals and patients with CGL. The observed difference in heat sensitivity of
CFU-GM from normal blood and marrow accords with other data suggesting that the two progenitor cell
compartments are distinct: the blood CFU-GM may represent a more primitive population of committed
progenitor cells. In CGL, CFU-GM in the blood may much more closely resemble those in the marrow. The
data provide no support for the hypothesis that malignant cells differ intrinsically from their normal
counterparts in respect of sensitivity to damage by hyperthermia.
The heat sensitivity of normal and malignant cells
is of obvious importance in considering the
prospects for hyperthermia in the treatment of
various forms of cancer. A number of studies (Chen
& Heidelberger, 1969; Giovanella et al., 1976; Kase
& Hahn 1975; Stehlin et al., 1975) have suggested
that malignant cells "per se" may be more heat
sensitive than normal cells i.e. that malignant
transformation confers increased heat sensitivity.
Other reports, however, (Ossovski & Sachs 1967;
Kachani 1969; Harisiadis, et al., 1975) indicated no
differences between the heat sensitivities of normal
and malignant cells, or that the normal cells were
the more sensitive. The interpretation of these
reports, however, is complicated by the variety of
end-points used (not all of them acceptable
measures of clonogenic cell survival) and by
attempts to compare the sensitivities of cells from
different tissues, or even different species.
Recently, Symonds et al. (1981) compared the
heat sensitivities of normal murine haemopoietic
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stem cells (colony forming units in spleen, CFU-S)
with that of L1210 leukaemic clonogenic cells by
heating the cells in vitro and assaying the response
by colony formation in mouse spleen. They
reported that marrow-derived leukaemic cells were
considerably more sensitive than marrow-derived
normal CFU-S, but leukaemic cells derived from
ascites fluid were as resistant as the normal marrow
cells. These results emphasise the importance of
cellular environment, as contrasted with intrinsic
sensitivity, in determining sensitivity to heat, but
nevertheless provide some grounds for expecting
that neoplastic cells might be more heat-sensitive
than the corresponding normal cells, under at least
some circumstances. However, these studies were in
mice. and employed the chemically induced L1210
leukaemia, a well-characterised but highly artificial
cell line whose relevance to the behaviour of
spontaneous human neoplasms is uncertain.
The present study was designed to explore the
heat sensitivities of human normal and neoplastic
cells of the same tissue type using the same
clonogenic assay as end-point of response. The
investigation was a comparison of the heat
sensitivities (in the range 41.5°C-44.0°C) of
granulocyte/macrophage committed progenitor cells
(CFU-GM) derived from both peripheral blood
and bone marrow of normal subjects and of
patients with chronic granulocytic leukaemia
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(CGL), a monoclonal neoplasm of spontaneous
origin. It was hoped that such a study would go at
least some way towards providing a basis for the
comparison of heat sensitivities of normal and
malignant cells of like type. It should be noted,
however, that not all criteria of "fair comparison"
are satisfied - in particular that CFU-GM derived
from normal subjects may have different cell kinetic
status from those of CFU-GM derived from CGL
patients. However, elaborate studies, probably
utilising the methods of flow cytometry, would be
necessary to guarantee cell kinetic comparability
and it seems reasonable that the more
straightforward investigations be carried out in the
first instance.
Materials and methods
Peripheral blood (60ml) was obtained from normal
volunteers (equal numbers of males and females)
and from CGL patients attending the
Hammersmith Hospital. Bone marrow cells were
obtained from normal subjects acting as marrow
transplant donors and from CGL patients from
whom marrow was collected for diagnostic studies.
All CGL patients were Ph'-chromosome positive;
none was in the 'blastic' phase of the diease.
Cellpreparation
Normal blood obtained by venous puncture was
placed in 20ml conical bottom test tubes (Sterilin
Ltd., Middlesex, England) with gas-tight caps, each
containing 200 I.U. of preservative-free heparin, and
centrifuged at lOOg for 10min. The white cell layer
(buffy coat) was removed and washed twice with
Hanks' balanced salt solution without calcium or
magnesium (Hanks' BSS, Gibco Europe Ltd.,
Uxbridge, U.K.). Buffy coat cells from CGL
patients were obtained by means of a continuous
flow blood-cell separator (American Instrument
Company, Maryland, USA) and washed twice with
Hanks' BSS. Marrow aspirated from normal
donors or from CGL patients was diluted 1:5 with
Hanks' BSS plus 200 I.U. of heparin and
centrifuged at lOOg for 10min. The washed buffy
coat cells were then resuspended in a medium
(Gibco Europe Ltd.) supplemented with 20% foetal
calf serum (Sera-lab Ltd., Sussex, England), 100
unitsml- 1 penicillin and 100mgml-1 streptomycin,
to a final concentration of 105 cellsml 1 for CGL
blood, CGL marrow and normal marrow or 1-
4 x 106 cellsml- 1 for normal blood.
The cells were incubated to remove adherent cells
in 25cm2 culture flasks (Sterilin Ltd.) at 37°C and
4% CO2 for 2h and the resulting non-adherent
cells were used for heat sensitivity studies.
Heat treatment
Human blood or marrow non-adherent cells
(3 x 105 cells from CGL blood, CGL marrow or
normal marrow and 3 - 12 x 106 cells from normal
blood) in 3ml supplemented a medium were split
into 0.3ml to 1.0ml samples in conical botton test
tubes (Sterilin Ltd.). They were placed in a
precision-controlled water bath at 37°C for 5min.
All samples except for the control were then
transferred to a water bath set at the test
temperature, heated for varying lengths of time and
then returned to the 37°C water bath till the end of
the experiment. All samples were then removed and
assayed for CFU-GM colony formation.
CFU-GM assay
Heat-treated and control cells (0.1 ml) were plated
in 35mm petri dishes (Nunc, Denmark) in a
volume of 1 ml containing 0.3% agar in
supplemented a medium and 10% human leucocyte
conditioned medium (HLCM) (Aye et al., 1974)
which contains colony stimulating activity (CSA).
The cells were plated at concentrations equivalent
to 105 initial cellsml -1 for CGL blood, CGL
marrow and normal marrow and 1 - 4 x 106 initial
cellsml 1 for normal blood. After incubation for 10
days at 37°C in 4% CO2 the number of colonies
(aggregates of .50 cells) was counted. In some
experiments the concentration of HCLM was varied
from 0.5% to 15%. The maximum number of
colonies occurred at 5% to 15% concentration for
both heated and unheated cells, indicating that the
heat treatment had not altered the sensitivity of
CFU-GM to the CSA in HCLM.
Computation ofsurvival curve parameters
In order to quantify the CFU-GM survival, the
data resulting from heat treatment at each fixed
temperature, for various lengths of time, were
fitted to a "multitarget function" of the form
S= 1-(1-exp(-D/Do))"
where S is the fraction of CFU-GM surviving (i.e. ratio of mean number of colonies in heated/control groups), D is the treatment time at the temperature
concerned (acting as a measure of the "dose" given) and Do and n are the survival curve parameters to
be estimated.
The function was used since, although some
curves showed evidence of "continuing curvature", the majority appeared to be of the type having an
initial "shoulder" followed by an exponential
portion. Estimation was carried out by visual
inspection of the data to determine first the
exponential portion of the survival, then fitting aSENSITIVITY OF CFU-GM TO HYPERTHEPRMIA 747
straight line relating lnS to D using- the method of
least squares. The Do value is then the reciprocal of
the slope of the fitted line, whose intercept on the
y-axis is ln(n). A useful estimate of the "shoulder
width" of the curve is then provided by the
"quasithreshold dose" DQ which is defined as
DQ=DOln(n)
This procedure was repeated for each temperature
for which survival data was available, to provide
survival curve parameters (DO,DQ) over a range of
temperatures.
Arrhenius analysis
The killing of cells by heat is frequently described
by the classical Arrhenius equation (see Westra &
Dewey 1971)
Rate of cell killing=Aexp(-E/RT)
where E is the Activation Energy, T the Absolute
Temperature, R the Gas Constant and A is a
constant.
Now,
Rate of cell killing=
(Time to reach final end-point)1
For a purely exponential survival curve, the time to
reach the fixed end-point may usefully be taken as
the Do value of the survival curve. For a
"shouldered" curve, the appropriate definition of
end-point is less obvious, especially since the
available data, if few, may preclude confident
discrimination between the "shouldered" and
exponential portions of the curve. In this analysis,
the end-point was taken to be a cell survival value
of 0.1, and the time taken to reach this end-point
(denoted Do,) provides a measure of the reciprocal
of the rate ofcell killing.
Thus
(/IDo 1)=A exp (-E/RT)
From which, rearranging,
ln(Do.1)= -In A + (-)
so that a plot of ln(Do1) against I/T should yield a
straight line of slope E/R. The Activation Energy E
is then the product of the measured slope of the
Arrhenius plot with the Gas Constant R.
Results
The results are shown in Figures 1-3 and in Table
I. Figure 1 shows the effects of heating at various
temperatures on survival of CFU-GM derived from
peripheral blood of normal subjects (Figure la) or
CGL patients (Figure lb). Figure 2 provides an
example at a single temperature, 42.5°C, of the
survival of CFU-GM derived from either blood or
marrow of normal subjects and from either blood
or marrow of CGL patients. Table I presents a
summary of survival curve parameter (DO and DQ
values) at various temperatures for all experimental
groups. Only in the case of normal blood CFU-GM
was it considered appropriate (on statistical
grounds) to carry out an Arrhenius analysis for
activation energy, and a form of the Arrhenius
curve for these data (plotting lnDO1 against 1/T) is
shown in Figure 3.
Discussion
The results indicate that CFU-GM from normal
peripheral blood are consistently less sensitive to
heat than CFU-GM from normal marrow or CGL
CFU-GM from either blood or marrow, the last 3
groups of survival curves being similar to one
another. There is some indication that the
difference between the heat sensitivities of normal
blood CFU-GM and CFU-GM from normal
marrow or from leukaemic blood or marrow is
more pronounced at lower temperatures. The
impression is confirmed by inspection of the
survival curve parameters given in Table I, showing
a higher Do for normal blood CFU-GM at all
temperatures, but no significant differences between
the other groups. Insofar as the Do values may be
taken as representative of the "heat sensitivity" of a
cell type, these data do not show a consistent
difference between the sensitivities of normal as
compared with neoplastic cells, since, although
normal blood CFU-GM were relatively resistant,
the Do values for normal marrow CFU-GM do not
differ significantly from those for CFU-GM from
either CGL blood or CGL marrow.
The origin of the apparent differences in heat
sensitivity between normal blood CFU-GM and
other groups is not clear. It is tempting to
speculate, however, that this effect could result
from some difference in the nature of CFU-GM
present in the blood as compared to the marrow of
normal individuals, this difference being lost in
CGL. There is evidence that, in the case of normal
subjects, CFU-GM derived from peripheral blood
differ from CFU-GM derived from marrow. For
example, blood-derived CFU-GM give rise to many
more eosinophilic colonies than do bone marrow
CFU-GM (Verma et al., 1980); they also differ in
sedimentation velocity and in the proportion of
cells which are cycling under steady-state conditions
(Tebbi et al., 1976). These observations suggest that748 M.J. BLACKBURN et al.
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Figure 1 Effect of heating for various times and temperatures on the surviving fraction (S) of CFU-GM
derived from peripheral blood of (a) normal subjects (b) CGL patients.50
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Figure 2 This shows an example, at a single temperature, 42.5°C, the effect of heating time on surviving
fraction (S) of CFU-GM derived from blood (0 0) or marrow (0 O) of normal subjects or from
blood (A /A) or marrow (A A) of CGL patients. The indicated uncertainties are standard errors of
the mean.
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Figure 3 Arrhenius plot showing temperature
dependence of time to reduce clonogenic surviving
fraction of normal blood CFU-GM to a surviving
fraction of 0.1 (denoted Do.). The ordinate of the
graph is the natural logarithm ofDO1 and the abscissa
is the reciprocal of the absolute temperature (°K). The
"best lines" above and below the "break point" at
42.5°C have been fitted by eye.
blood and marrow CFU-GM may belong to
discrete maturational compartments and may
possess a number of different properties.
Differences in heat sensitivity could then be
interpreted as providing further evidence for the
distinct nature of blood and marrow CFU-GM. No
comparable difference was seen between blood and
marrow CFU-GM in CGL, however, possibly
because, in this disease, blood CFU-GM readily
exchange with and are in other regards
indistinguishable from bone marrow CFU-GM.
This hypothesis appears consistent with some of the
known properties of granulopoiesis in CGL
(Goldman et al., 1974); whether it is correct in this
case remains speculative.
If the heat sensitivity of blood CFU-GM dose
differ from that of marrow CFU-GM, at least in
normal individuals, it would be important to ensure
that the lesser sensitivity of the more accessible
blood CFU-GM were not taken as representative
of the sensitivity of marrow CFU-GM, e.g. in
assessing haemopoietic tolerance to total body
hyperthermia. Such considerations could be
particularly important if hyperthermia were to be
combined with myelosuppressive drugs, a
combination which may, in any case, result in
unfavourable therapeutic differentials (Honess &
Bleehen, 1982).
Of the available data, only those for normal
blood CFU-GM were deemed to be sufficiently
extensive to warrant Arrhenius analysis to
determine the activation energy of the lethal
process. The resultant Arrhenius plot (Figure 3)
shows a transition at about 42.5°C. Below this
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"break point", the Activation Energy is calculated
to be 1756kJmole-1°C-1, but is 928kJmole-1C-1
above this point. These activation energy values
correspond to an increase of heating time per 1C0
temperature change (to maintain iso-effective cell
survival) by a factor of 5.4 at temperatures below
the transition point, falling to a factor of 2.8 at
temperatures above it. This may be compared with
a factor of 6 at temperatures below transition, and
a factor of 2 at temperatures above it which have
been proposed by Field & Morris (1983) as typical
for a variety of cells and tissues, based on an
extensive review. The implication of the present
findings is that the transition is, in the case of
CFU-GM, broadly similar to, but rather less sharp
than, the corresponsing transition for other cells
and tissues. These results are similar to values
deduced from data recently published by Bromer et
al. (1982) on the heat sensitivity of CFU-GM
derived from human bone marrow. They differ,
however, from those reported by Elkon & McGrath
(1981) on the heat sensitivity of granulopoietic
precursor cells (CFU-D) in mouse bone marrow
assayed with an in vivo diffusion chamber
technique. Elkon & McGrath observed a "break
point" at 43.5°C, with activation energies of
882kJmole-1 C-1 and 349kJmole-1 C-1 below
and above this point. This difference could be due
to CFU-D being at an earlier stage of maturation
than CFU-GM.
It is interesting to compare the present findings
with those of Symonds et al. (1981, 1984) on the
heat sensitivity of normal "stem cells" (CFU-S) and
leukaemic clonogenic cells in the DBA2 mouse.
Symonds et al. (1981) found mouse haemopoietic
cells (both normal and leukaemic) to be very sensi-
tive to heat; considerably more so than appears to
be the case for human CFU-GM, as evidenced by
the present findings and those of Bromer et al.
(1982) or for mouse CFU-D as reported by Elkon
& McGrath (1981). In addition, Symonds et al.
(1981) observed a significant difference in the heat
sensitivities of normal and leukaemic cells derived
from bone marrow. However, the activation
energies for normal and leukaemic cells were
similar, approximately 945kJmole - C-1 with no
evidence of a "break point" within the temperature
range 42°C-440C. The absolute heat sensitivities
were found to be strongly influenced by nutritional
milieu (Symonds et al., 1984).
If, as seems possible, differences of cell position
within a hierarchical lineage (e.g. CFU-S versus
CFU-D or CFU-GM), species differences, different
assay conditions and nutritional milieu effects all
contribute to the observed differences in heat
sensitivity, then extensive investigations may be
necessary to determine the hyperthermia
sensitivities of different cell lineages of the
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haemopoietic system under clinically relevant
conditions.
In conclusion:
(1) The heat sensitivity of CFU-GM derived
from normal human blood, was, for all
temperatures within the range 41.50C-44.00C,
consistently less than that of CFU-GM derived
from normal bone marrow, and less than those of
CFU-GM derived from either blood or marrow of
CGL patients.
(2) The heat sensitivity of normal marrow CFU-
GM was not consistently different from that of
CGL CFU-GM, wherether derived from blood or
marrow. Hence, there was no clear-cut evidence for
an intrinsic increase in heat sensitivity conferred by
malignant transformation, at least in CGL.
(3) The relative heat resistance of normal blood
CFU-GM might reflect a maturational or kinetic
difference in CFU-GM derived from blood from
that of marrow of normal individuals. In CGL it is
possible that these differences are abolished because
"marrow type" CFU-GM circulate in blood.
(4) Arrhenius analysis was possible only for
normal blood CFU-GM. For this case, the
activation energy for heat killing of CFU-GM was
1756kJmole-1 aC-1 at temperatures below 42.5°C
and 928 kJmole-1 C- 1 at temperatures above it.
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